Comparison Overview

Hyderabad Pharmaceutical Congress Committee

VS

Merck Group

Hyderabad Pharmaceutical Congress Committee

None
Last Update: 2025-12-09
Between 750 and 799

HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketing etc. Show more Show less

NAICS: 325
NAICS Definition:
Employees: 10,001
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Merck Group

Frankfurter Str. 250, Darmstadt, DE, 64293
Last Update: 2025-12-09
Between 800 and 849

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 32,133
Subsidiaries: 3
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/hyderabad-pharmaceutical-congress-committee.jpeg
Hyderabad Pharmaceutical Congress Committee
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/merck-group.jpeg
Merck Group
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Hyderabad Pharmaceutical Congress Committee
100%
Compliance Rate
0/4 Standards Verified
Merck Group
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Hyderabad Pharmaceutical Congress Committee in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Merck Group in 2025.

Incident History — Hyderabad Pharmaceutical Congress Committee (X = Date, Y = Severity)

Hyderabad Pharmaceutical Congress Committee cyber incidents detection timeline including parent company and subsidiaries

Incident History — Merck Group (X = Date, Y = Severity)

Merck Group cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/hyderabad-pharmaceutical-congress-committee.jpeg
Hyderabad Pharmaceutical Congress Committee
Incidents

No Incident

https://images.rankiteo.com/companyimages/merck-group.jpeg
Merck Group
Incidents

No Incident

FAQ

Merck Group company demonstrates a stronger AI Cybersecurity Score compared to Hyderabad Pharmaceutical Congress Committee company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Merck Group company has disclosed a higher number of cyber incidents compared to Hyderabad Pharmaceutical Congress Committee company.

In the current year, Merck Group company and Hyderabad Pharmaceutical Congress Committee company have not reported any cyber incidents.

Neither Merck Group company nor Hyderabad Pharmaceutical Congress Committee company has reported experiencing a ransomware attack publicly.

Neither Merck Group company nor Hyderabad Pharmaceutical Congress Committee company has reported experiencing a data breach publicly.

Neither Merck Group company nor Hyderabad Pharmaceutical Congress Committee company has reported experiencing targeted cyberattacks publicly.

Neither Hyderabad Pharmaceutical Congress Committee company nor Merck Group company has reported experiencing or disclosing vulnerabilities publicly.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds any compliance certifications.

Neither company holds any compliance certifications.

Merck Group company has more subsidiaries worldwide compared to Hyderabad Pharmaceutical Congress Committee company.

Merck Group company employs more people globally than Hyderabad Pharmaceutical Congress Committee company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds SOC 2 Type 1 certification.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds SOC 2 Type 2 certification.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds ISO 27001 certification.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds PCI DSS certification.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds HIPAA certification.

Neither Hyderabad Pharmaceutical Congress Committee nor Merck Group holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

NXLog Agent before 6.11 can load a file specified by the OPENSSL_CONF environment variable.

Risk Information
cvss3
Base: 8.1
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:H
Description

uriparser through 0.9.9 allows unbounded recursion and stack consumption, as demonstrated by ParseMustBeSegmentNzNc with large input containing many commas.

Risk Information
cvss3
Base: 2.9
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L
Description

A vulnerability was detected in Mayan EDMS up to 4.10.1. The affected element is an unknown function of the file /authentication/. The manipulation results in cross site scripting. The attack may be performed from remote. The exploit is now public and may be used. Upgrading to version 4.10.2 is sufficient to fix this issue. You should upgrade the affected component. The vendor confirms that this is "[f]ixed in version 4.10.2". Furthermore, that "[b]ackports for older versions in process and will be out as soon as their respective CI pipelines complete."

Risk Information
cvss2
Base: 5.0
Severity: LOW
AV:N/AC:L/Au:N/C:N/I:P/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

MJML through 4.18.0 allows mj-include directory traversal to test file existence and (in the type="css" case) read files. NOTE: this issue exists because of an incomplete fix for CVE-2020-12827.

Risk Information
cvss3
Base: 4.5
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:C/C:L/I:N/A:L
Description

A half-blind Server Side Request Forgery (SSRF) vulnerability exists in kube-controller-manager when using the in-tree Portworx StorageClass. This vulnerability allows authorized users to leak arbitrary information from unprotected endpoints in the control plane’s host network (including link-local or loopback services).

Risk Information
cvss3
Base: 5.8
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:C/C:H/I:N/A:N